Sectors & IndustriesConsumer Defensive

Best Consumer Staple Stocks to Buy Now (2026)

Top consumer staple stocks in 2026 ranked by overall Due Diligence Score. See the best consumer staple stocks to buy now, according to analyst forecasts for the consumer defensive sector.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best consumer staple stocks to buy right now are:

Afya (NASDAQ:AFYA) is the #1 top consumer staple stock out of 253 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Afya (NASDAQ:AFYA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: C.

Afya (NASDAQ:AFYA) has a Due Diligence Score of 64, which is 33 points higher than the consumer staple sector average of 31. It passed 25 out of 38 due diligence checks and has strong fundamentals. Afya has seen its stock lose -12.4% over the past year, overperforming other consumer staple stocks by 17 percentage points.

Afya has an average 1 year price target of $17.75, an upside of 12.7% from Afya's current stock price of $15.75.

Afya stock has a consensus Sell recommendation according to Wall Street analysts. Of the 4 analysts covering Afya, 0% have issued a Strong Buy rating, 0% have issued a Buy, 75% have issued a Hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

Sanfilippo John B & Son (NASDAQ:JBSS) is the #2 top consumer staple stock out of 253 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Sanfilippo John B & Son (NASDAQ:JBSS) is: Value: B, Growth: C, Momentum: C, Sentiment: B, Safety: A, Financials: B, and AI: C.

Sanfilippo John B & Son (NASDAQ:JBSS) has a Due Diligence Score of 40, which is 9 points higher than the consumer staple sector average of 31. It passed 14 out of 38 due diligence checks and has average fundamentals. Sanfilippo John B & Son has seen its stock return 20.62% over the past year, overperforming other consumer staple stocks by 50 percentage points.

Sanfilippo John B & Son has an average 1 year price target of $109.00, an upside of 34.73% from Sanfilippo John B & Son's current stock price of $80.90.

Sanfilippo John B & Son stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Sanfilippo John B & Son, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Natures Sunshine Products (NASDAQ:NATR) is the #3 top consumer staple stock out of 253 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Natures Sunshine Products (NASDAQ:NATR) is: Value: B, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Natures Sunshine Products (NASDAQ:NATR) has a Due Diligence Score of 35, which is 4 points higher than the consumer staple sector average of 31. It passed 14 out of 38 due diligence checks and has average fundamentals. Natures Sunshine Products has seen its stock return 121.21% over the past year, overperforming other consumer staple stocks by 151 percentage points.

Natures Sunshine Products has an average 1 year price target of $33.00, an upside of 25.57% from Natures Sunshine Products's current stock price of $26.28.

Natures Sunshine Products stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Natures Sunshine Products, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 82 consumer staple stocks that have issued dividends in the past year, the 3 consumer staple stocks with the highest dividend yields are:

B&G Foods (NYSE:BGS) has an annual dividend yield of 14.29%, which is 11 percentage points higher than the consumer staple sector average of 3.23%. B&G Foods's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. B&G Foods's dividend has not shown consistent growth over the last 10 years.

B&G Foods's dividend payout ratio of -140.7% indicates that its high dividend yield might not be sustainable for the long-term.

Cal Maine Foods (NASDAQ:CALM) has an annual dividend yield of 10.35%, which is 7 percentage points higher than the consumer staple sector average of 3.23%. Cal Maine Foods's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Cal Maine Foods's dividend has shown consistent growth over the last 10 years.

Cal Maine Foods's dividend payout ratio of 54.9% indicates that its high dividend yield is sustainable for the long-term.

Conagra Brands (NYSE:CAG) has an annual dividend yield of 9.52%, which is 6 percentage points higher than the consumer staple sector average of 3.23%. Conagra Brands's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Conagra Brands's dividend has shown consistent growth over the last 10 years.

Conagra Brands's dividend payout ratio of -1,555.6% indicates that its high dividend yield might not be sustainable for the long-term.

Consumer staple stocks were up 0.19% in the last day, and down -1.56% over the last week. Hims & Hers Health was the among the top gainers in the consumer defensive sector, gaining 11.12% yesterday.

Hims & Hers Health shares are trading higher after Health Secretary Robert F. Kennedy Jr. recently announced that U.S. drug regulators will loosen peptide injection regulations. Also, B of A Securities raised its price target on the stock from $21 to $25.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued consumer staple stocks right now are:

Herbalife (NYSE:HLF) is the most undervalued consumer staple stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Herbalife has a valuation score of 57, which is 31 points higher than the consumer staple sector average of 26. It passed 4 out of 7 valuation due diligence checks.

Herbalife's stock has gained 159.13% in the past year. It has overperformed other stocks in the consumer staple sector by 188 percentage points.

Afya (NASDAQ:AFYA) is the second most undervalued consumer staple stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Afya has a valuation score of 100, which is 74 points higher than the consumer staple sector average of 26. It passed 7 out of 7 valuation due diligence checks.

Afya's stock has dropped -12.4% in the past year. It has overperformed other stocks in the consumer staple sector by 17 percentage points.

Usana Health Sciences (NYSE:USNA) is the third most undervalued consumer staple stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Usana Health Sciences has a valuation score of 43, which is 17 points higher than the consumer staple sector average of 26. It passed 3 out of 7 valuation due diligence checks.

Usana Health Sciences's stock has dropped -18.65% in the past year. It has overperformed other stocks in the consumer staple sector by 11 percentage points.

41.73% of consumer staple stocks rated by analysts are a strong buy right now. On average, analysts expect consumer staple stocks to rise by 16.86% over the next year.

4.82% of consumer staple stocks have a Zen Rating of A (Strong Buy), 12.65% of consumer staple stocks are rated B (Buy), 73.49% are rated C (Hold), 6.63% are rated D (Sell), and 2.41% are rated F (Strong Sell).